Revenue grew 37% to a record $2.739bn last quarter and management raised the fiscal-2028 outlook to $18bn — yet the stock fell 10.3% the next morning and sits 36% below its June high. Marvell sells the connective tissue that attaches to somebody else’s compute; the debate is whether that attach point is a moat or a queue position. Six analyst lenses, three scenarios, four horizons.
Gray line = Marvell’s actual price into today: $127.48 all-time high (Jan 23, 2025) → $47 on the April 2025 tariff shock → $61.44 52-week low (Sep 4, 2025) → $329.88 52-week high (Jun 18, 2026) → a $163.40 trough on Jul 29 → $210.39 now. Colored paths are synthesized scenario midpoints, probability-weighted bear 30% · base 45% · bull 25%. Log price axis — the stock has traded a 5.4× range in twelve months, so a linear axis would flatten the history into a line. The last four months are compressed at the right of the history panel because the time axis is continuous; that near-vertical spike and plunge is real, not an artifact. Wall Street’s 12-month consensus is $284.80 (range $143–$400, “Strong Buy” from 39 of 44 analysts, S&P Global, Sep 1, 2026).
Those probabilities are a judgment call — so make them yours. We start bear-tilted at 30 / 45 / 25 because the multiple, not the business, is doing most of the work here. Drag to set how likely the bear and bull cases are (base takes the remainder); the blended target below, the dotted line on the chart, and the prob-weighted row of every scenario card update live.
Each lens was reasoned independently before reading the others, so the disagreement is real rather than staged. Targets are 12-month and each states the multiple behind it. The mean of the six is $217.50 — meaningfully below the Street’s $284.80, which is the honest summary of this desk’s view.
A company that has raised its forward outlook twice in two quarters, while growth accelerates, does not get a cyclical multiple mid-inflection.
Marvell’s differentiator was never winning the ASIC bid; it is owning every metre of the link around it. The question is whether the plumbing keeps you in the room when the compute contract is re-bid.
Strip away the product detail and this is a geared bet on 2027 hyperscaler capex — the single most consensual assumption in the market right now.
The counter-intuitive finding: on its own multiple history MRVL is close to fair. What has broken is the momentum factor, and the beta means you are not paid for that.
Revenue is up 30.6% over twelve months. Free cash flow margin went down. At 107× trailing free cash flow you are underwriting a conversion improvement that has not yet appeared.
The $120bn Google headline is a vesting schedule, not an order book. Strip the story out and you own a 79%-data-center business with a handful of customers at 50× forward earnings.
Every target below was published on Aug 28, 2026, the morning after the Q2 print, except Goldman Sachs (mid-August, Neutral). The striking feature is not the average — it is that after a 10.3% one-day drop, almost nobody cut. The Street reads the sell-off as timing, not thesis. That unanimity is itself a risk factor.
Individual targets via TipRanks / S&P Global as of Sep 1, 2026. Ratings distribution: 31 strong buy, 8 buy, 5 hold, 0 sell. Mean $284.80, median $280, low $143, high $400. Goldman’s $195 Neutral predates the Q2 report; on Sep 1 the firm reiterated that Marvell “demands caution” while calling Broadcom a buy. Note that twelve of these sixteen sit above this desk’s own base case of $265.
Every price below is an EPS path multiplied by an exit multiple — nothing more. The clay row is the probability-weighted blend and is wired to the sliders above: change the weights and it moves. Bars are normalised within each card, so bull is always full width. These are illustrative frameworks, not forecasts.
Marvell’s fiscal year ends in late January, so FY2027 is the year ending Jan 31, 2027. A 12-month target discounts the fiscal year ending roughly sixteen months out — a September 2027 price reflects FY2029 earnings. Anchors are hard: FY2026 non-GAAP EPS of $2.84 is reported; FY2027E $4.20 and FY2028E $6.70 are S&P Global consensus (33 analysts). Everything from FY2029 is this desk’s modelling.
Base case. Management’s own $18bn FY2028 target lands, custom silicon clears $10bn in FY2029, and the non-GAAP operating margin holds in the 38–40% band. Revenue compounds toward roughly $23–24bn in FY2029 at a ~40% operating margin and an 11% non-GAAP tax rate, on a diluted share count drifting toward ~930M as stock compensation and early Google warrant tranches vest. The multiple compresses from 50× forward today to 24× by 2031 — still a premium to Broadcom’s ~20×, justified by a faster growth rate off a smaller base.
Bear case. Hyperscaler capex digests through calendar 2027–28. Google keeps Broadcom as primary and Marvell’s tranche revenue arrives late and thin; custom mix drags blended gross margin below 55%; FY2028 lands near $15bn rather than $18bn. The multiple resets to the low-20s and then the high-teens. Note the shape: the bear path troughs in year two and recovers — a digestion cycle, not a terminal decline. Even so, the two-year drawdown is 44%.
Bull case. The Google relationship compounds faster than the vesting cadence implies, Celestial AI’s Photonic Fabric becomes a genuine third leg past FY2029, and operating margin pushes above 42% as custom scales on fixed engineering. This is the world in which Marvell stops being priced as a second source.
Why 30 / 45 / 25. The default tilts bearish because valuation, not the business, carries the risk here: 50× FY2027 earnings and 19.5× trailing sales against a five-year sales multiple closer to 8×. The business is executing; the price already assumes it keeps executing. Move the sliders if you disagree — that is what they are for.
This is the single most useful chart in the report, because the bull and bear cases both live in the gap between the blue bar and the green one. Revenue roughly doubles from FY2024 to FY2027E. Free cash flow does not keep pace — the FCF margin has fallen from 24.2% in FY2025 to 18.3% on a trailing basis. Debt is drifting up, not down. Scale is arriving; conversion is the open question.
Reported figures from Marvell fiscal-year results and S&P Global (through the quarter ended Aug 1, 2026). FY2027E revenue is management’s own $12bn outlook given Aug 27, 2026; FY2027E free cash flow $2.70bn is consensus; capex is this desk’s estimate rolled forward from $470M trailing; debt is the Aug 1, 2026 balance. Marvell remains only modestly levered — management put net debt to adjusted EBITDA at 0.27× — so the balance sheet is not the risk. The conversion line is.
Non-GAAP diluted EPS. Gray bars are reported; green bars are forward. FY2027 and FY2028 are S&P Global consensus; FY2029 is this desk’s model, drawn with a dashed edge to say so. The ladder is steep — earnings roughly 5.9× from FY2024 to FY2029E — which is precisely why a 50× forward multiple can look either reckless or reasonable depending on how much of that ladder you believe.
Reported figures from Marvell’s fiscal-year results: FY2024 $1.51, FY2025 $1.57, FY2026 $2.84 (up 81% year on year). FY2027 quarterly run-rate so far: Q1 $0.80, Q2 $0.94, Q3 guided to $1.10 ± $0.05 — which implies roughly $1.36 in Q4 to reach the $4.20 consensus, consistent with management entering its 38–40% operating-margin band in that quarter. Watch the gray-to-green step. The whole investment case is that FY2026’s $2.84 becomes FY2028’s $6.70 without a stumble.
Sorted slowest to fastest. Olive bars are the reported core — what Marvell actually delivered in the quarter ended Aug 1, 2026. Clay bars are the frontier lines: management’s guided growth for the businesses that are supposed to carry the next two years. If growth is intact while the stock is 36% off its high, that disconnect is the bull case in one picture — and the bear’s reply is that the June high was the mistake, not the September price.
Reported growth is Q2 FY2027 versus the year-ago quarter (Marvell earnings release, Aug 27, 2026). Guided growth is management’s own framing on the same call: FY2027 revenue ~$12bn (~+45%), FY2028 ~$18bn (~+50%), data center +60% in FY2027, interconnect above +70%, custom silicon more than doubling in FY2028 and exceeding $10bn in FY2029. Communications and other — the old carrier and enterprise business — is now just 21% of revenue and grew 10%; it no longer moves the stock either way.
Each side stated as its best advocate would put it, with the evidence attached. Both cases are built from the same August 27 earnings release — which is what makes this stock genuinely contested rather than merely volatile.
Not a list of everything that could go wrong — a map of where each risk lives. The hot corner is deliberately occupied by multiple compression rather than anything operational, because that is the honest reading: Marvell’s business risks are mostly possible, while its valuation risk is likely. One genuine tail risk sits at the bottom right.
What breaks: at ~50× FY2027 earnings, a de-rate toward Broadcom’s ~20× forward costs more than two full years of earnings growth. Nothing operational has to go wrong for this one to hurt.
What breaks: the $18bn FY2028 guide assumes no pause. A single quarter of digestion at two or three customers resets the entire estimate ladder and the multiple at the same time.
What breaks: data center is 79% of revenue across a handful of programs. Losing one XPU generation removes roughly a year of growth — exactly what the January-to-April 2025 collapse from $127 to the high $40s priced.
What breaks: Marvell is fabless and leading-edge dependent. A Taiwan supply interruption or a new control regime on advanced AI silicon severs the roadmap regardless of how many design wins are booked. Low odds, total consequence.
What breaks: non-GAAP gross margin is already guided down to 57.5–58.5% from 58.9% because custom is accelerating. If custom outgrows optics faster than modelled, the 38–40% operating margin target slips right.
What breaks: tranches vest at ~240,000 shares per $500M of qualifying purchases through FY2033. If the purchase cadence lags, the $120bn headline simply never converts into the years investors are underwriting.
What breaks: Broadcom holds ~70% of custom AI silicon share. A second source has limited pricing power when the primary decides to defend a socket.
What breaks: Credo holds roughly 88% of the AEC market and Astera Labs owns retimers and CXL. Marvell’s full-distance claim gets contested lane by lane by focused specialists.
What breaks: beta 2.25, 0.11% dividend yield, sub-1% free cash flow yield. A long-duration equity with no carry is the first thing sold when bond yields back up, as on Sep 1, 2026.
What breaks: $3.25bn paid, with revenue not expected until the second half of FY2028. A slip pushes the $1bn FY2029 photonics contribution out and removes the third leg from the bull case.
Hover the dotted terms in the metrics strip above, or scan the desk’s working definitions here.